User profiles for "author:J Herod"
 | Jonathan HerodDirector of Transformation, Hamad Medical Corporation Women's Hospital Verified email at hamad.qa Cited by 6064 |
[HTML][HTML] Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
…, K Godfrey, R Gunu, M Habib, R Hallett, J Herod… - The Lancet, 2016 - thelancet.com
Background Ovarian cancer has a poor prognosis, with just 40% of patients surviving 5
years. We designed this trial to establish the effect of early detection by screening on ovarian …
years. We designed this trial to establish the effect of early detection by screening on ovarian …
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
…, S Dobbs, S Essapen, J Twigg, J Herod… - The Lancet, 2015 - thelancet.com
Background The international standard of care for women with suspected advanced ovarian
cancer is surgical debulking followed by platinum-based chemotherapy. We aimed to …
cancer is surgical debulking followed by platinum-based chemotherapy. We aimed to …
[HTML][HTML] Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence …
Background Ovarian cancer has a high case–fatality ratio, with most women not diagnosed
until the disease is in its advanced stages. The United Kingdom Collaborative Trial of …
until the disease is in its advanced stages. The United Kingdom Collaborative Trial of …
Radical vaginal trachelectomy as a fertility‐sparing procedure in women with early‐stage cervical cancer—cumulative pregnancy rate in a series of 123 women
JH Shepherd, C Spencer, J Herod… - BJOG: An International …, 2006 - Wiley Online Library
Objective To analyse the fertility rates, complications and recurrences in a group of women
who have undergone radical vaginal trachelectomy and pelvic lymphadenectomy for early …
who have undergone radical vaginal trachelectomy and pelvic lymphadenectomy for early …
The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.
Modulation of apoptosis may influence resistance to chemotherapy and therefore affect the
outcome of cancer treatment. Ovarian cancer, one of the most fatal malignancies in women …
outcome of cancer treatment. Ovarian cancer, one of the most fatal malignancies in women …
[HTML][HTML] Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort
Background The increase in the worldwide incidence of endometrial cancer relates to rising
obesity, falling fertility, and the ageing of the population. Transvaginal ultrasound (TVS) is a …
obesity, falling fertility, and the ageing of the population. Transvaginal ultrasound (TVS) is a …
[HTML][HTML] Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United …
Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected
Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of …
Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of …
The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma
Advanced ovarian cancer is characterized by poor prognosis and the development of
resistance to chemotherapy. We have found that Bcl-2 and p53, two proteins implicated in …
resistance to chemotherapy. We have found that Bcl-2 and p53, two proteins implicated in …
Recruitment to multicentre trials—lessons from UKCTOCS: descriptive study
…, S Lewis, A Lopez, K Godfrey, D Oram, J Herod… - Bmj, 2008 - bmj.com
Objective To describe the factors that contributed to successful recruitment of more than 200
000 women to the UK Collaborative Trial of Ovarian Cancer Screening, one of the largest …
000 women to the UK Collaborative Trial of Ovarian Cancer Screening, one of the largest …
Risk of epithelial ovarian cancer in asymptomatic women with ultrasound‐detected ovarian masses: a prospective cohort study within the UK collaborative trial of …
…, R Rangar, K Godfrey, D Oram, J Herod… - … in obstetrics & …, 2012 - Wiley Online Library
Objective To estimate the risk of primary epithelial ovarian cancer (EOC) and slow growing
borderline or Type I and aggressive Type II EOC in postmenopausal women with adnexal …
borderline or Type I and aggressive Type II EOC in postmenopausal women with adnexal …